Baricitinib statistically significantly reduced COVID-19-related mortality: a systematic review and meta-analysis of five phase III randomized, blinded and placebo …
S Manoharan, L Ying Ying - Biology Methods and Protocols, 2024 - academic.oup.com
Background Due to high heterogeneity and risk of bias (RoB) found in previously published
meta-analysis, a concrete conclusion on the efficacy of baricitinib in reducing mortality in …
meta-analysis, a concrete conclusion on the efficacy of baricitinib in reducing mortality in …
Heterogeneity and Risk-of-Biases are No Longer the Issues to Conclude the Effectiveness of Baricitinib in Reducing COVID-19 Related Mortality: A Systematic Review …
S Manoharan, LY Ying - medRxiv, 2022 - medrxiv.org
Background Due to high heterogeneity and risk of bias (RoB) in previously published meta-
analysis, a concrete conclusion on the efficacy of baricitinib in reducing mortality in COVID …
analysis, a concrete conclusion on the efficacy of baricitinib in reducing mortality in COVID …
HASH (0x55d844d4e9b0)
C Wild, S Wolf, G Goetz, M Walter, J McEntee… - 2020 - eprints.aihta.at
(Re-) Konvaleszenzplasma ist Plasma, das von Patient* innen gewonnen wird, die sich von
einer covid19 Erkrankung bereits erholt haben, und kann an Patient* innen abgegeben …
einer covid19 Erkrankung bereits erholt haben, und kann an Patient* innen abgegeben …